• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

合成及具有口服活性的氨基官能化螺 1,2,4-三噁烷类抗疟药物的评估。

Synthesis and antimalarial assessment of a new series of orally active amino-functionalized spiro 1,2,4-trioxanes.

机构信息

Division of Medicinal & Process Chemistry, Central Drug Research Institute, Lucknow-226001, India.

出版信息

J Med Chem. 2010 Nov 11;53(21):7587-98. doi: 10.1021/jm100678p.

DOI:10.1021/jm100678p
PMID:20936847
Abstract

Keto-trioxanes 7a-d, easily accessible in two steps from allylic alcohols 5a-d, underwent reductive amination with substituted anilines to furnish amino-functionalized trioxanes 8a-i, 9a-i, 10a-i, and 11a-i. All these new trioxanes were assessed for their oral antimalarial activity against multidrug-resistant Plasmodium yoelii nigeriensis in Swiss mice. 2-Naphthalene-based trioxanes 9c and 9i, the most active compounds of the series, provided 100% protection to the malaria-infected mice at 24 mg/kg × 4 days, while the related trioxane 9b and phenanthrene-based trioxane 11e provided a similar level of protection at 48 mg/kg × 4 days. All other trioxanes, except 10c, 10d, and 10g, provided 100% protection at 96 mg/kg × 4 days. In this model, β-arteether provided 100% protection at 48 mg/kg × 4 days and 20% protection at 24 mg/kg × 4 days.

摘要

Keto-trioxanes 7a-d 可通过两步从烯丙醇 5a-d 轻松获得,与取代苯胺进行还原胺化,得到氨基功能化的三氧杂环己烷 8a-i、9a-i、10a-i 和 11a-i。所有这些新的三氧杂环己烷都在瑞士小鼠中评估了其对多药耐药性 Plasmodium yoelii nigeriensis 的口服抗疟活性。基于 2-萘的三氧杂环己烷 9c 和 9i 是该系列中最有效的化合物,在 24 mg/kg×4 天时对感染疟疾的小鼠提供了 100%的保护,而相关的三氧杂环己烷 9b 和菲三氧杂环己烷 11e 在 48 mg/kg×4 天时提供了类似水平的保护。除了 10c、10d 和 10g 之外,所有其他三氧杂环己烷在 96 mg/kg×4 天时都提供了 100%的保护。在该模型中,β-青蒿素在 48 mg/kg×4 天时提供了 100%的保护,在 24 mg/kg×4 天时提供了 20%的保护。

相似文献

1
Synthesis and antimalarial assessment of a new series of orally active amino-functionalized spiro 1,2,4-trioxanes.合成及具有口服活性的氨基官能化螺 1,2,4-三噁烷类抗疟药物的评估。
J Med Chem. 2010 Nov 11;53(21):7587-98. doi: 10.1021/jm100678p.
2
Orally active 1,2,4-trioxanes: synthesis and antimalarial assessment of a new series of 9-functionalized 3-(1-arylvinyl)-1,2,5-trioxaspiro[5.5]undecanes against multi-drug-resistant plasmodium yoelii nigeriensis in mice.口服活性1,2,4-三恶烷:针对小鼠体内多重耐药性约氏疟原虫尼氏亚种的一系列新型9-官能化3-(1-芳基乙烯基)-1,2,5-三氧杂螺[5.5]十一烷的合成与抗疟评估
J Med Chem. 2006 May 4;49(9):2794-803. doi: 10.1021/jm051130r.
3
New adamantane-based spiro 1,2,4-trioxanes orally effective against rodent and simian malaria.新型基于金刚烷的螺环1,2,4-三氧杂环己烷对啮齿动物和猿类疟疾具有口服疗效。
J Med Chem. 2007 Feb 8;50(3):521-7. doi: 10.1021/jm0610043.
4
6-(4'-Aryloxy-phenyl)vinyl-1,2,4-trioxanes: a new series of orally active peroxides effective against multidrug-resistant Plasmodium yoelii in Swiss mice.6-(4'-芳氧基-苯基)乙烯基-1,2,4-三恶烷:一类新型口服活性过氧化物,对瑞士小鼠中的多药耐药性约氏疟原虫有效。
Bioorg Med Chem Lett. 2010 Aug 1;20(15):4459-63. doi: 10.1016/j.bmcl.2010.06.045. Epub 2010 Jun 12.
5
Novel bis- and tris-1,2,4-trioxanes: synthesis and antimalarial activity against multidrug-resistant Plasmodium yoelii in Swiss mice.新型双-和三-1,2,4-三恶烷:瑞士小鼠体内对多重耐药约氏疟原虫的合成及抗疟活性
J Med Chem. 2008 Dec 11;51(23):7581-92. doi: 10.1021/jm801006v.
6
Synthesis and antimalarial activity of a new series of trioxaquines.一系列新型三氧喹啉的合成及其抗疟活性
Bioorg Med Chem. 2004 Mar 1;12(5):1177-82. doi: 10.1016/j.bmc.2003.11.021.
7
Orally active antimalarials: synthesis and bioevaluation of a new series of steroid-based 1,2,4-trioxanes against multi-drug resistant malaria in mice.口服活性抗疟药:针对小鼠多药耐药疟疾的一系列新型甾体基1,2,4-三氧杂环己烷的合成与生物评价
Bioorg Med Chem Lett. 2007 Aug 1;17(15):4097-101. doi: 10.1016/j.bmcl.2007.05.055. Epub 2007 May 23.
8
New orally active spiro 1,2,4-trioxanes with high antimalarial potency.具有高抗疟效力的新型口服活性螺环[1,2,4]三恶烷
Bioorg Med Chem Lett. 2005 Oct 15;15(20):4484-7. doi: 10.1016/j.bmcl.2005.07.013.
9
Orally active 1,2,4-trioxepanes: synthesis and antimalarial activity of a series of 7-arylvinyl-1,2,4-trioxepanes against multidrug-resistant Plasmodium yoelii in Swiss mice.口服活性1,2,4-三氧杂环庚烷:一系列7-芳基乙烯基-1,2,4-三氧杂环庚烷对瑞士小鼠体内多重耐药约氏疟原虫的合成及抗疟活性
Bioorg Med Chem. 2008 Feb 15;16(4):1816-21. doi: 10.1016/j.bmc.2007.11.012. Epub 2007 Nov 6.
10
Bile acid-based 1,2,4-trioxanes: synthesis and antimalarial assessment.基于胆汁酸的 1,2,4-三噁烷:合成与抗疟评估。
J Med Chem. 2012 Dec 13;55(23):10662-73. doi: 10.1021/jm301323k. Epub 2012 Nov 30.

引用本文的文献

1
Mechanistic Evaluation of the Stability of Arylvinyl-1,2,4-trioxanes under Acidic Conditions for Their Oral Administration as an Antimalarial Drug.作为抗疟药物口服给药时芳基乙烯基-1,2,4-三恶烷在酸性条件下稳定性的机理评估
ACS Omega. 2022 May 17;7(21):17984-17994. doi: 10.1021/acsomega.2c01321. eCollection 2022 May 31.
2
Reduction of the Double Bond of 6-Arylvinyl-1,2,4-trioxanes Leads to a Remarkable Increase in Their Antimalarial Activity against Multidrug-Resistant in a Swiss Mice Model.在瑞士小鼠模型中,6-芳基乙烯基-1,2,4-三恶烷双键的还原导致其对多重耐药疟原虫的抗疟活性显著增加。
ACS Omega. 2021 Nov 4;6(45):30790-30799. doi: 10.1021/acsomega.1c05041. eCollection 2021 Nov 16.
3
Synthesis and antimalarial activity of 3,3-spiroanellated 5,6-disubstituted 1,2,4-trioxanes.
3,3-螺环缩合的5,6-二取代1,2,4-三恶烷的合成及其抗疟活性
ACS Med Chem Lett. 2012 Dec 11;4(2):165-9. doi: 10.1021/ml300188t. eCollection 2013 Feb 14.
4
Recent advances in malaria drug discovery.疟疾药物发现的最新进展。
Bioorg Med Chem Lett. 2013 May 15;23(10):2829-43. doi: 10.1016/j.bmcl.2013.03.067. Epub 2013 Mar 27.